Beauty Health CO SKIN
We take great care to ensure that the data presented and summarized in this overview for Beauty Health Co is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SKIN
View all-
Janus Henderson Group PLC London, X011.3MShares$28.4 Million0.03% of portfolio
-
Luxor Capital Group, LP New York, NY6.81MShares$17.2 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.68MShares$14.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.56MShares$14 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL4.87MShares$12.3 Million5.48% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.79MShares$9.54 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA3.5MShares$8.82 Million0.38% of portfolio
-
Woodline Partners LP San Francisco, CA3.13MShares$7.88 Million0.13% of portfolio
-
Morgan Stanley New York, NY2.6MShares$6.54 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.9MShares$4.78 Million0.0% of portfolio
Latest Institutional Activity in SKIN
Top Purchases
Top Sells
About SKIN
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Insider Transactions at SKIN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 09
2024
|
Daniel Copell Watson Chief Revenue Oficer |
BUY
Grant, award, or other acquisition
|
Direct |
243,506
+23.14%
|
-
|
|
Apr 09
2024
|
Marla Malcolm Beck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
837,662
+43.72%
|
-
|
|
Apr 09
2024
|
Michael P. Monahan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
292,207
+26.11%
|
-
|
|
Nov 29
2023
|
Bradley Hauser Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
176,711
+31.15%
|
-
|
|
Nov 29
2023
|
Daniel Copell Watson Chief Revenue Oficer |
BUY
Grant, award, or other acquisition
|
Direct |
156,250
+21.66%
|
-
|
|
Nov 29
2023
|
Michael P. Monahan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
176,711
+24.84%
|
-
|
|
Nov 20
2023
|
Marla Malcolm Beck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
213,675
+47.04%
|
-
|
|
Aug 17
2023
|
Brian Christopher Miller Director |
BUY
Open market or private purchase
|
Direct |
60,000
+39.62%
|
$300,000
$5.81 P/Share
|
|
Aug 17
2023
|
Michael D Capellas Director |
BUY
Open market or private purchase
|
Direct |
30,000
+13.18%
|
$180,000
$6.03 P/Share
|
|
Aug 17
2023
|
Michael P. Monahan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.38%
|
$30,000
$6.02 P/Share
|
|
Aug 17
2023
|
Andrew Roy Stanleick Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
16,485
+2.29%
|
$98,910
$6.05 P/Share
|
|
Aug 16
2023
|
Julius Few Director |
BUY
Open market or private purchase
|
Direct |
20,454
+15.01%
|
$122,724
$6.1 P/Share
|
|
Aug 16
2023
|
Doug K. Schillinger Director |
BUY
Open market or private purchase
|
Direct |
33,000
+33.86%
|
$198,000
$6.11 P/Share
|
|
Aug 16
2023
|
Brent L Saunders Director |
BUY
Open market or private purchase
|
Direct |
59,380
+1.01%
|
$356,280
$6.1 P/Share
|
|
Aug 10
2023
|
Michael P. Monahan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
353,107
+50.0%
|
-
|
|
Jul 07
2023
|
Michelle C. Kerrick Director |
BUY
Other acquisition or disposition
|
Direct |
6,779
+15.06%
|
-
|
|
Jul 07
2023
|
Lcp Edge Holdco LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,207,261
-8.77%
|
-
|
|
Jun 14
2023
|
Marla Malcolm Beck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+37.83%
|
-
|
|
Jun 14
2023
|
Michelle C. Kerrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
|
Jun 14
2023
|
Michael D Capellas Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.58M shares |
|---|---|
| Open market or private purchase | 224K shares |
| Other acquisition or disposition | 6.78K shares |
| Other acquisition or disposition | 3.21M shares |
|---|